Pluri (PLUR) Exchange Rate Effect (2021 - 2025)
Pluri (PLUR) posted quarterly Exchange Rate Effect of -$62000.0 for Q4 2025, up 86.67% year-over-year from -$33214.3 in Q4 2024, and down 6300.0% quarter-over-quarter from $1000.0 in Q3 2025.
Pluri (PLUR) Exchange Rate Effect (2021 - 2025) Analysis & Trends
Pluri (PLUR) has reported Exchange Rate Effect for 5 consecutive years, with -$62000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Exchange Rate Effect rose 86.67% year-over-year to -$62000.0; the TTM figure through Dec 2025 stood at $557000.0 (up 1077.19% YoY), while the FY2025 annual figure was $177000.0, up 1509.09% from the prior year.
- Exchange Rate Effect retreated to -$62000.0 in Q4 2025 per PLUR's latest filing, from $1000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.1 million in Q2 2022 and bottomed at -$1.1 million in Q4 2023.
- Historically, Exchange Rate Effect has averaged $132631.6 across 5 years, with a median of $24000.0 in 2024.
- On a YoY basis, Exchange Rate Effect climbed as much as 1078.79% in 2023 and fell as far as 313.36% in 2023.
- Pluri's Exchange Rate Effect stood at $1.6 million in 2021, then plunged by 116.99% to -$277000.0 in 2022, then slumped by 313.36% to -$1.1 million in 2023, then surged by 59.39% to -$465000.0 in 2024, then soared by 86.67% to -$62000.0 in 2025.
- Business Quant data shows PLUR's Exchange Rate Effect at -$62000.0 in Q4 2025, $1000.0 in Q3 2025, and $127000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | - |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 | -39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -62,000.00 |
| Dec 31, 2025 | -62,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Mar 31, 2025 | 491,000.00 |
| Mar 31, 2025 | 491,000.00 |
| Dec 31, 2024 | -465,000.00 |
| Dec 31, 2024 | -465,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Mar 31, 2024 | 427,000.00 |
| Mar 31, 2024 | 427,000.00 |
| Dec 31, 2023 | -1.15 Mn |
| Dec 31, 2023 | -1.15 Mn |
| Sep 30, 2023 | 772,000.00 |
| Sep 30, 2023 | 772,000.00 |